Imaging the renin-angiotensin-aldosterone system in the heart
- 61 Downloads
The influence of the renin-angiotensin system (RAS) is recognized in cardiac and vascular injury. An extrinsic RAS has been known for decades, and an equally important intrinsic RAS has been discovered recently. The latter leads to pathologic tissue alterations in the absence of systemic stimuli and may be the main source of local tissue effects of RAS. A new radiotracer [18F]fluorobenzoyl-lisinopril was synthesized by radiolabeling benzoic acid active ester with 18F and reacting that with the epsilon-amino group of lisinopril. The presence of angiotensin-converting enzyme (ACE) activity and angiotensin II receptors was examined in relation to myocardial fibrosis. This tissue-specific radioligand represents the first study of ACE in the human heart. This article presents preliminary data on imaging the RAS in the human cardiac tissue and discusses the potential for clinical application of these imaging techniques to human patients.
KeywordsAldosterone Lisinopril Angiotensin Converting Enzyme Activity Zofenopril Dilsizian Versus
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 6.Bader M: Role of the local renin-angiotensin system in cardiac damage: a mini-review focusing on transgenic animal models. J Mol Cell Cardiol 2002, 34:1455–1462. This is a concise review of the tissue RAS and its implications in the development of hypertensive heart disease.PubMedCrossRefGoogle Scholar
- 11.Neri Serneri GG, Boddi M, Coppo M, et al.: Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation 1996, 94:1886–1896.Google Scholar
- 12.Neri Serneri GG, Boddi M, Cecioni I, et al.: Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 2001, 88:961–971.Google Scholar
- 13.Dilsizian V: Myocardial viability: reversible left ventricular dysfunction. In Atlas of Nuclear Cardiology. Edited by Dilsizian V, Narula J. Philadelphia: Current Medicine Inc.; 2003:131–145.Google Scholar
- 15.Nguyen G, Delarue F, Burckle C, et al.: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular response to renin. J Clin Invest 2002, 109:1417–1427. A plasma membrane receptor for renin is described for the first time by this group of investigators, emphasizing the role of the cell surface in AII generation.PubMedCrossRefGoogle Scholar
- 31.Hayashi M, Tsutamoto T, Wada A, et al.: Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior myocardial infarction. Circulation 2003, 107:2559–2565.PubMedCrossRefGoogle Scholar
- 42.Pandurangi RS: Metallated angiotensin converting enzyme inhibitors: synthesis and biological applications [abstract]. Am Chem 2000, 22:S220.Google Scholar
- 43.Lee YHC, Kiesewetter DO, Lang L, et al.: Synthesis of 4-[18F]fluorobenzoyllisinopril: a radioligand for angiotensin converting enzyme (ACE) imaging with positron emission tomography. J Labelled Comp Radiopharm 2001, 44:S268-S270.Google Scholar
- 44.Dilsizian V, Shirani J, Lee YHC, et al.: Specific binding of [18F] fluorobenzoyl-lisinopril to angiotensin converting enzyme in human heart tissue of ischemic cardiomyopathy. Circulation 2001, 104:II-694.Google Scholar
- 48.Shirani J, Loredo ML, Dilsizian V: Evidence for disparate distribution of mast cell chymase and angiotensin converting enzyme in per-infarct and non-infarct myocardium in ischemic cardiomyopathy. J Invest Med 2003, 51(Suppl 2):S366.Google Scholar